Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy.

about

Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy.

Item

http://www.wikidata.org/entity/Q47107456

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Detection level and pattern of ...... ng prior to radiation therapy.

@en

Detection level and pattern of ...... ng prior to radiation therapy.

@nl

type

Item

label

Detection level and pattern of ...... ng prior to radiation therapy.

@en

Detection level and pattern of ...... ng prior to radiation therapy.

@nl

prefLabel

Detection level and pattern of ...... ng prior to radiation therapy.

@en

Detection level and pattern of ...... ng prior to radiation therapy.

@nl

P1476

Detection level and pattern of ...... ng prior to radiation therapy.

@en

P2093

Chukwuka Eze

http://www.w3.org/2001/XMLSchema#string

Claus Belka

http://www.w3.org/2001/XMLSchema#string

Maximilian Niyazi

http://www.w3.org/2001/XMLSchema#string

Minglun Li

http://www.w3.org/2001/XMLSchema#string

Nina-Sophie Schmidt-Hegemann

http://www.w3.org/2001/XMLSchema#string

Paul Rogowski

http://www.w3.org/2001/XMLSchema#string

Peter Bartenstein

http://www.w3.org/2001/XMLSchema#string

Ute Ganswindt

http://www.w3.org/2001/XMLSchema#string

Wolfgang Peter Fendler

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.

Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.

Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.

Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.

PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer

(68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients.

Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells.

Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study.

P2888

s13014-017-0902-0

P304

176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-017-0902-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Buchner

Christian G Stief

P577

2017-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092618118

http://www.w3.org/2001/XMLSchema#string

P698

29126446

http://www.w3.org/2001/XMLSchema#string

P932

5681820

http://www.w3.org/2001/XMLSchema#string